Rare Kidney Cancer Provides Better Understanding on the Role
of Metabolic Changes In Cancer
Researchers in The Cancer Genome Atlas (TCGA) Network have made a number of new findings
about the biology and development of a rare form of kidney cancer. They found that the disease – chromophobe renal
cell carcinoma (ChRCC) – stems in part from alterations in genes in the mitochondria, the cell’s energy supplier.
They also discovered that the tumor is characterized by genetic rearrangements near a gene important in DNA repair
and in maintaining telomerase, the enzyme which determines a cell’s lifespan. Finally, investigators also found
that ChRCC is a distinct disease and shares few genomic characteristics with other kidney cancers.
In the study – the most extensive genomic view of ChRCC to date – investigators led by Chad Creighton, Ph.D.,
Baylor College of Medicine, Houston, and Kimryn Rathmell, M.D., Ph.D., University of North Carolina, Chapel Hill,
performed a complex array of analyses, including examining the entire genomes of 50 of the 66 ChRCC tumors studied,
a high number for a rare cancer. The study revealed increased numbers of mitochondria as well as mutations in
mitochondrial DNA. This led researchers to discover that ChRCC tumors favor a different energy-generating process
than that used by the more common clear cell kidney cancer. In addition, their findings are the first to show
specific alterations affecting the TERT gene that could affect cancer development, and might help
explain its increased expression – and deregulation – in cancer. Overall, the findings provide new insights into the development of
more common forms of kidney cancer, and shed light on the role of mitochondria and metabolic pathways in cancer.
The results also support the growing realization that both the cancer’s genomic characteristics and cell of
origin matter, as many cancers consist of several individual diseases that require specific therapies. TCGA is a
collaboration jointly supported and managed by the National Cancer Institute (NCI) and the National Human Genome
Research Institute (NHGRI), both parts of the National Institutes of Health. The researchers reported their
results online August 21, 2014 in Cancer Cell.
News Source: http://www.cancer.gov/newscenter/newsfromnci/2014/TCGAkidneyChromophobe